We deal with vaccinations. Part 9. Hepatitis B

2024 Author: Seth Attwood | [email protected]. Last modified: 2023-12-16 15:55

1. If there is anything more stupid than vaccinating a teenager against HPV, it will certainly vaccinate a newborn baby against hepatitis B.

2. Like HPV, hepatitis B is a virus that is transmitted primarily through sexual contact or blood. If the mother is infected with hepatitis B, the virus can pass to the baby through the placenta or during childbirth. Hepatitis B does not pass through breast milk. [12]

3. In 80% of infected adults, the disease goes away without symptoms, or with very mild symptoms, and they do not even know they were sick. Once infected, they gain lifelong immunity.

Of the remaining 20% who are diagnosed with hepatitis B, 95% recover completely and receive lifelong immunity.

Of the remaining 5%, only 25% (i.e. 0.25% of all those infected) will develop, 20-30 years after infection, liver cirrhosis or cancer. This cirrhosis or cancer does not develop because of the virus itself, but because of the immune response to it.

70% of patients with hepatitis B are drug addicts, gays, alcoholics, homeless people who have many sexual partners.

Hepatitis B passes into cirrhosis or cancer mainly in alcoholics, smokers, patients with hepatitis C, obesity and diabetes.

4. Why vaccinate a newborn child against STDs, which he practically cannot get infected? Well, simply because adult drug addicts and gays refused to be vaccinated. Therefore, it was decided to vaccinate children immediately after birth, when they are not yet able to refuse.

5. Usually three doses of the vaccine are given. The first is right after birth; the second - a month; and the third at 6 months. This is the only vaccine given immediately after childbirth (except for BCG, which is so ineffective that it is almost never used anywhere in the world). If you think the vaccine is given right after birth to prevent possible infection from the mother, then no. In the United States and other countries, all women are tested for hepatitis B before giving birth. Children of infected mothers receive immunoglobulin (passive vaccination) along with the vaccine.

In some countries, however, all children are vaccinated simply because it is much cheaper than testing all mothers.

6. Before the universal vaccination of infants began in 1990, only 1 in 100,000 children under 15 had hepatitis B in the United States. Currently, the chance of contracting hepatitis B before age 20 is 0.3 per million. In developed countries, hepatitis B is a rather rare disease. In Africa and in Southeast Asia, it is much more common.

7. The first hepatitis B vaccine appeared in 1981. It was made on the basis of a live virus, and after its introduction, the number of people infected with hepatitis B increased rapidly. In a 1994 study, it was found that despite the availability of the vaccine, the number of patients with hepatitis B does not decrease.

8. There are many manufacturers of this vaccine, but in developed countries they mainly use Recombivax (Merck) and Engerix-B (GSK), as well as combination vaccines.

Engerix-B contains aluminum hydroxide and Recombivax amorphous aluminum hydrogen phosphate (AAHS, the same adjuvant that contains Gardasil). Recombivax contains twice as much aluminum (500mcg vs. 250mcg).

Previously, the packaging of Recombivax indicated that it contains aluminum hydroxide. Now they write it like this: 0.5 mg of aluminum provided as aluminum hydroxyphosphate sulfate, previously referred to as aluminum hydroxide. This is the question of how much you can trust the list of vaccine ingredients.

Both vaccines are grown in yeast and therefore contain 1% yeast protein, which could lead to yeast allergies.

9. In most European countries, newborns are not vaccinated against hepatitis B, but are vaccinated 2-3 months after birth. In some countries (Finland, Iceland, Denmark, Hungary), children are not vaccinated against hepatitis B at all, but there are no epidemics there. On the contrary, the death rate from hepatitis B in them is much lower than the European average.

10. Clinical trials of the safety of these vaccines did not have a control group at all, since it is considered highly unethical not to vaccinate a newborn infant against STDs, which he practically cannot get infected with.

Several studies:

11. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. (Hernán, 2004, Neurology)

Those vaccinated against hepatitis B, three years after vaccination, suffered from multiple sclerosis 3.1 times more often than those who were not vaccinated.

It also analyzes several other studies that did not find an increased risk of multiple sclerosis in those vaccinated. For example, here's a study that found no increased risk. This is because they used the date of diagnosis, not the date of the first symptoms. The diagnosis of multiple sclerosis is usually made several years after the onset of symptoms.

12. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. (Mikaeloff, 2009, Neurology)

Engerix-B vaccine increased the risk of multiple sclerosis 2.77-fold compared to other hepatitis B vaccines.

13. Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination. (Houézec, 2014, Immunol Res)

Since the introduction of the hepatitis B vaccine in France, the number of cases of multiple sclerosis has increased by 65%. There is a high correlation (0.93 / 0.73) between the number of vaccine doses given and the number of cases of multiple sclerosis in 1–2 years.

14. A case-control study of serious autoimmune adverse events following hepatitis B immunization. (Geier, 2005, Autoimmunity)

VAERS analysis. Adults vaccinated against hepatitis B developed multiple sclerosis 5.2 times more often than those vaccinated against tetanus. The risk of vasculitis was 2.6 times higher, hair loss 7.2 times, lupus 9 times, arthritis 2 times, rheumatoid arthritis 18 times, thrombocytopenia 2 times, inflammation of the optic nerve 14 times higher.

15. Adverse events associated with hepatitis B vaccine in U. S. children less than six years of age, 1993 and 1994. (Fisher, 2001, Ann Epidemiol)

Vaccination against hepatitis B increased the risk of arthritis by 5.9 times, acute otitis media by 1.6 times, and pharyngitis by 1.4 times.

16. Hepatitis B vaccine and liver problems in U. S. children less than 6 years old, 1993 and 1994. (Fisher, 1999, Epidemiology)

Vaccination against hepatitis B increased the risk of liver disease by 1.5-2.3 times.

17. Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002. (Gallagher, 2010, J Toxicol Environ Health A.)

Newborn boys vaccinated against hepatitis B had a 3 times higher risk of developing autism, compared with unvaccinated, or vaccinated at least one month after birth.

18. Autoimmune hazards of hepatitis B vaccine. (Girard, 2005, Autoimmun Rev)

A review article on the autoimmune consequences of hepatitis B vaccination, and how this vaccine is combined with evidence-based medicine (not at all).

19. Delayed acquisition of neonatal reflexes in newborn primates receiving a thimerosal-containing hepatitis B vaccine: influence of gestational age and birth weight. (Hewitson, 2010, J Toxicol Environ Health A.)

Newborn monkeys were vaccinated against hepatitis B with thiomersal, and compared with unvaccinated ones.

The vaccinated macaques acquired survival reflexes, as well as motor and sensory-motor reflexes, much later than the unvaccinated ones. Low weight and premature birth exacerbated the effect.

Thiomersal (ethyl mercury) has not been added to vaccinations since 2003 in the United States and Western Europe, but is still used in other countries. In Canada, for example. Not to mention Russia, Eastern Europe and third world countries..

20. Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years. (Gallagher, 2008, Toxicol Environ Chem)

Those vaccinated against hepatitis B had a 9 times higher risk of developmental disability than those who were not vaccinated.

21. Clustering of Cases of IDDM 2 to 4 Years after Hepatitis B Immunization is Consistent with Clustering after Infections and Progression to IDDM in Autoantibody Positive Individuals. (Classen, 2008, Open Pediatr Med J)

Since the start of the vaccination campaign, the number of children with type 1 diabetes has increased by 61% in France and 48% in New Zealand.

In Italy, those vaccinated against hepatitis B suffered from juvenile diabetes 40% more than those who were not vaccinated.

An increase in the number of cases of juvenile diabetes occurs 2-4 years after the start of vaccination, which hints at a causal relationship.

22. Chronic fatigue syndrome and fipomyalgia following immunization with the hepatitis B vaccine: another angle of the 'autoimmune (auto-inflammatory) syndrome induced by adjuvants' (ASIA). (Agmon-Levin, 2014, Immunol Res)

Hepatitis B vaccine has been associated with chronic fatigue syndrome and fibromyalgia.

23. Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases. (Zafrir, 2012, Lupus)

ASIA, or Schonfeld's Syndrome, is the generic term for autoimmune diseases caused by adjuvants and includes the autoimmune effects of aluminum adjuvants, Gulf war syndrome, macrophage myositis (MMF) and siliconosis (autoimmune effects of silicone implants). It leads to neurological and psychiatric symptoms, cognitive impairment, muscle pain, arthritis, chronic fatigue, insomnia, vision and gastrointestinal problems, etc.

It analyzes 93 cases associated with the hepatitis B vaccine.

24. Vaccine-induced autoimmunity. (Cohen, 1996, J Autoimmun)

Autoimmune diseases such as Reiter's syndrome, arthritis, lupus, inflammation of the choroid, myasthenia gravis, erythema nodosum, thrombocytopenic purpura, Evans syndrome, and demyelinating diseases of the central nervous system are associated with hepatitis B vaccination.

25. In vivo study of hepatitis B vaccine effects on inflammation and metabolism gene expression. (Hamza, 2012, Mol Biol Rep.)

Epigenetic effect of the vaccine. The mice received one or two hepatitis B vaccinations (at the appropriate dose). After one day, they had significant changes in the expression of 144 genes in the liver. The authors analyzed in detail 7 of them. All changes were negative and resulted in mild liver injury. Mainly because of the aluminum.

26. Hepatitis B vaccine induces apoptotic death in Hepa1-6 cells. (Hamza, 2012, Apoptosis)

The hepatitis B vaccine destroys mitochondria and kills liver cells in mice.

27. Trained immunity in newborn infants of HBV-infected mothers. (Hong, 2015, Nature Comm)

The hepatitis B virus transmitted from mother to child may, contrary to popular belief, lead to better development of the immune system.

28. Vertical HBV transmission in Jerusalem in the vaccine era. (Michaiel, 2012, Harefuah)

The hepatitis B vaccine does not work at all in babies who are born to infected mothers.

This study reports that less than 4% of babies born to infected mothers contracted the infection themselves.

29. Chronic hepatitis B infection in adolescents who received primary infantile vaccination. (Wu, 2013, Hepatology)

Fifteen-year-olds who were vaccinated as children were tested for hepatitis B antibodies and were found to be very low. That is, immunity from vaccination ends even before the onset of sexual activity, when it finally becomes necessary.

According to another study, antibodies disappear by the age of five.

30. VAERS has recorded 999 deaths of children under one year of age and 390 disabilities following hepatitis B vaccine in the United States. (that is, the real amount is 10-100 times more)

31. The Israeli Sci-B-Vac vaccine has been used in Israel since 2005. But only in the center of Israel and in the south (because you cannot give the entire market to one manufacturer). This vaccine was withdrawn in July 2015.

It was recalled, according to a statement from the health ministry, because the ampoules were entering the labeling machine too quickly, which could theoretically cause micro-cracks and bacterial contamination. No contaminated ampoules were found, so the population was asked not to worry, but the vaccine was withdrawn. Two years have passed since then, but the vaccine has not returned to the market. Probably, they could not solve the problem of sticking labels.

32. Sci-B-Vac is the third generation vaccine. The first generation was a live vaccine. The second generation is a recombinant (genetically modified) vaccine containing virus-like particles. The third generation vaccine contains two more antigens in addition, and therefore produces a stronger immune response.

The only published clinical trial of a vaccine involved 150 children. The vaccine has not received an FDA approval. The protocol of the commission of the Ministry of Health, which authorized the vaccination in Israel, disappeared somewhere.

Many parents in the FB groups claim that children from this vaccine had severe side effects, developmental delays, etc. This is not very surprising, since it contained twice as much aluminum. It also has three antigens instead of one, further increasing the risk of an autoimmune reaction. Why this is happening will be discussed in another part.

The vaccine is also registered in Russia.

33. Lectures and interviews:

34. Ayurvedic medicine seems to cure acute and chronic hepatitis B.

35. Graphs of the number of cases and the number of deaths from hepatitis B, before and after the start of vaccination in the United States. Data provided by CDC.

UPD 12/8

36. How do vaccine advocates argue the need for this vaccine for infants? Let's listen to Paul Offit.

His first argument: the child can be infected from the mother passing through the birth canal. But, as we already know, in this case, the vaccine is still ineffective, you need to give an immunoglobulin.

The second argument: a child can be infected from someone else's toothbrush, or from some uncle. This method of infection is purely theoretical. There is not a single study that proves that any person contracted hepatitis B in this way.

Third argument: Those who get the vaccine immediately after birth are much more likely to end the entire series of three shots. No comment.

37. Hepatitis B appears to be also treated with vitamin C. [Baur, 1954], [Kirchmair, 1957], [Calleja, 1960], [Morishige, 1978], [Smith, 1988]

TL; DR: It makes sense to vaccinate children against hepatitis B only if you are planning a career in prostitution for them, or if the child shows homosexual tendencies, or if you fear that children will become drug addicts.

And even then, it makes no sense to vaccinate newborns, but it is worth waiting until the age of 18. The chance of contracting hepatitis B before the onset of sexual activity is practically zero.

Vaccines contain 250-500 mcg of aluminum. That is, three doses of this vaccine contain 15-30 times more aluminum than all the aluminum that a baby will receive from breast milk in 6 months. By the way, the fact that the baby usually receives aluminum from breast milk does not mean that this is normal. This means that mothers are poisoned with aluminum, which they receive through food and water, and use it to dispose of their babies.

The vaccine is most likely useless even for babies born to infected mothers.

Vaccination increases the risk of autoimmune diseases such as multiple sclerosis, arthritis, type 1 diabetes and many others.

In developed countries, the risk of complications from vaccination is much higher than the risk of complications from hepatitis B, and even much higher than the risk of contracting hepatitis B.